广发纳斯达克生物科技人民币(001092)
动态评分: 5.28分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2019-12-31 | PRTA | Prothena Corp plc | 12.55 | 0.08% |
2019-12-31 | CARA | Cara Therapeutics Inc | 10.52 | 0.07% |
2019-12-31 | CERS | Cerus Corp | 10.91 | 0.07% |
2019-12-31 | CLVS | Clovis Oncology Inc | 10.88 | 0.07% |
2019-12-31 | CYTK | Cytokinetics Inc | 11.43 | 0.07% |
2019-12-31 | RVNC | Revance Therapeutics Inc | 11.89 | 0.07% |
2019-12-31 | TVTX | Travere Therapeutics Inc | 11.28 | 0.07% |
2019-12-31 | ARDX | Ardelyx Inc | 8.96 | 0.06% |
2019-12-31 | KURA | Kura Oncology Inc | 9.13 | 0.06% |
2019-12-31 | MGNX | MacroGenics Inc | 9.14 | 0.06% |
2019-12-31 | PDLI | PDL BioPharma Inc | 9.67 | 0.06% |
2019-12-31 | TXMD | TherapeuticsMD Inc | 10.37 | 0.06% |
2019-12-31 | VYGR | Voyager Therapeutics Inc | 8.98 | 0.06% |
2019-12-31 | AMAG | AMAG Pharmaceutical Inc | 8.75 | 0.05% |
2019-12-31 | ANAB | AnaptysBio Inc | 7.64 | 0.05% |
2019-12-31 | LXRX | 莱斯康制药 | 8.7 | 0.05% |
2019-12-31 | PETQ | 宠物IQ | 8.14 | 0.05% |
2019-12-31 | PGNX | 普罗基尼克斯制药 | 7.45 | 0.05% |
2019-12-31 | SPPI | Spectrum Pharmaceuticals Inc | 7.5 | 0.05% |
2019-12-31 | AKBA | Akebia Therapeutics Inc | 7.13 | 0.04% |
公告&资料
